Targeting nf-κb signaling for multiple myeloma

Targeting nf-κb signaling for multiple myeloma

10.3390/cancers12082203

Saved in:

書目詳細資料
Main Authors:	Wong, A.H.-H., Shin, E.M., Tergaonkar, V., Chng, W.-J.
其他作者:	MEDICINE
格式:	Review
出版:	MDPI AG 2021
主題:	Biomarker-guided targeted therapy Multiple myeloma NF-?B Precision medicine
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/198599
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
由: Kannaiyan, R., et al.
出版: (2014)

IDENTIFICATION OF G9A AS A THERAPEUTICALLY TARGETABLE DRIVER OF MULTIPLE MYELOMA TUMORIGENESIS
由: ZHANG XIYUN
出版: (2020)

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma
由: Zhang, X.Y., et al.
出版: (2021)

IDENTIFICATION OF A NOVEL AGENT THAT CAN SUPPRESS PROLIFERATION, INDUCE APOPTOSIS AND OVERCOME CHEMORESISTANCE IN MULTIPLE MYELOMA
由: RADHAMANI KANNAIYAN
出版: (2014)

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
由: Shen, H.-M., et al.
出版: (2014)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
由: Davies, FE, et al.
出版: (2023)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
由: Davies, FE, et al.
出版: (2023)

MOLECULAR CHARACTERIZATION OF GREB1 AND TRAF3 IN THE ONCOGENIC SIGNALLING PATHWAYS OF HUMAN CANCER
由: SULTAN ABDA NEJA
出版: (2019)

TIPE2 induced the proliferation, survival, and migration of lung cancer cells through modulation of AKt/mTOR/NF-κB signaling cascade
由: Bordoloi, D., et al.
出版: (2021)

Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of multiple myeloma
由: Sikka, S., et al.
出版: (2014)

NF-κB signaling in neurite growth and neuronal survival
由: Yu, F., et al.
出版: (2014)

Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy
由: Li, F., et al.
出版: (2011)

Role of NF-κB in tumorigenesis
由: Shanmugam, M.K., et al.
出版: (2014)

Extramedullary plasmacytoma of the orbit as initial presentation of multiple myeloma
由: Razak, R.A., et al.
出版: (2016)

Transcriptional regulation during aberrant activation of NF-κB signalling in cancer
由: Deka, Kamalakshi, et al.
出版: (2023)

Transmembrane activator and caml interactor (Taci): Another potential target for immunotherapy of multiple myeloma?
由: Xu, S., et al.
出版: (2021)

Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
由: Somu, C., et al.
出版: (2021)

Attenuation of STAT3 signaling cascade by daidzin can enhance the apoptotic potential of bortezomib against multiple myeloma
由: Yang, M.H., et al.
出版: (2021)

STAT3: A Promising Therapeutic Target in Multiple Myeloma
由: Chong, Phyllis SY, et al.
出版: (2020)

CHARACTERISING THE METABOLIC PHENOTYPE OF C-MAF OVEREXPRESSION IN MULTIPLE MYELOMA
由: LIM SZE LYNN JULIA
出版: (2024)

Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling cascade
由: Jung Y.Y., et al.
出版: (2019)

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
由: Liu, Jin, et al.
出版: (2022)

A unique rhinologic manifestation of multiple myeloma
由: Seah, Jun Jie, et al.
出版: (2022)

Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in t(4;14) multiple myeloma
由: Xie, Z., et al.
出版: (2014)

Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study
由: Heong V., et al.
出版: (2020)

MANAGING UNCERTAINTY IN ONCOLOGY DRUG ASSESSMENTS: APPLICATIONS IN MULTIPLE MYELOMA
由: DIANA BEATRIZ SAMSON BAYANI
出版: (2024)

RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines
由: Naidu, V.G.M., et al.
出版: (2014)

Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma.
由: Zhou, Jianbiao, et al.
出版: (2022)

Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma
由: Zhou, Jianbiao, et al.
出版: (2022)

Centrosomes and myeloma; aneuploidy and proliferation
由: Chng, W.J., et al.
出版: (2016)

The role of NF-kB and histone deacetylase in gene regulation
由: CHEW SOO FEN, JOANNE CHRISTABELLE
出版: (2010)

ELUCIDATING THE ONCOGENIC ROLES OF MARCH5 IN MULTIPLE MYELOMA
由: HAMED BASHIRI
出版: (2024)

Management of treatment-emergent peripheral neuropathy in multiple myeloma
由: Richardson, P.G., et al.
出版: (2016)

Unraveling genomic instability in multiple myeloma - Mechanisms, biological and clinical implications
由: CHNG WEE JOO
出版: (2011)

Natural history and prognostic factors at first relapse in multiple myeloma
由: Wang, C., et al.
出版: (2021)

ELUCIDATING THE ROLE OF ADAR1 IN REGULATING IMMUNOTHERAPEUTIC RESPONSE IN MULTIPLE MYELOMA
由: KOH MUN YEE
出版: (2023)

Monocyte chemoattractant protein-1 (MCP-1) produced via NF-κB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats
由: Deng, Y.Y., et al.
出版: (2011)

IDENTIFY FUNCTIONAL PROTEINS INTERACTING WITH MMSET IN MULTIPLE MYELOMA
由: CHOOI JING YUAN
出版: (2018)

IDENTIFICATION OF AN EFFECTIVE RIBONUCLEOSIDE ANALOGUE AND IMMUNOMODULATORY IMIDE DRUG COMBINATION FOR MULTIPLE MYELOMA
由: WEIJIE WANG
出版: (2024)

SUPEROXIDE-MEDIATED ACTIVATION OF NF-kB SIGNALLING VIA REDOX-MEDIATED PP2A INACTIVATION
由: YEE YI HUI
出版: (2020)